These findings suggest that in HER2 + IBC, tumour-derived MIF interacts with CD74 on CD8+ T cells to activate p38 MAPK, which in turn drives NFAT1 nuclear translocation and transcriptional activation of LAG3 and TIGIT. Here, CD8A is linked to neoplasm.